[{"id":"32e67e72-a7dc-4ce5-9a04-0d11b361ae23","acronym":"","url":"https://clinicaltrials.gov/study/NCT05675605","created_at":"2023-01-09T15:59:22.674Z","updated_at":"2024-07-02T16:35:21.856Z","phase":"Phase 1/2","brief_title":"A Study of TY-1091 in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT05675605","lead_sponsor":"TYK Medicines, Inc","biomarkers":" RET","pipe":" | ","alterations":" RET fusion","tags":["RET"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e RET fusion"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TY-1091"],"overall_status":"Recruiting","enrollment":" Enrollment 248","initiation":"Initiation: 04/24/2023","start_date":" 04/24/2023","primary_txt":" Primary completion: 06/01/2025","primary_completion_date":" 06/01/2025","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2024-01-30"}]